跳至主要内容
临床试验/CTRI/2023/07/055665
CTRI/2023/07/055665尚未招募Unknown

A Retrospective Study to Understand the Clinical Characteristics andthe Treatment Patterns For HR positive, HER2 negative High-Risk Early Breast CancerPatients - NI

Clinart MENA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Adult women >=18 years of age (or per local regulations).
  • 2. The participant has confirmed HR+, HER2-, early-stage resected invasive breast cancer
  • without evidence of distant metastases.
  • 3. The participant must have undergone definitive surgery of the primary breast tumor.
  • 4. The participant must have tumor tissue from the breast (preferred) or lymph node.

排除标准

  • 1. Distant metastasis.
  • No other explicit exclusion criteria are defined to allow for documentation of routine clinical
  • practice as much as possible.

研究者

发起方
Clinart MENA

相似试验